Pharmaceutical and Healthcare Schistosomiasis Pipeline Review H1 2017 provides comprehensive information on the therapeutics under development for Schistosomiasis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Schistosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Preclinical and Discovery stages are 3, 3 and 2 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.
Companies Involved in Schistosomiasis Therapeutics Development Discussed - Kancera AB, LondonPharma Ltd, Merck KGaA, Salvensis
Drug Profile for Schistosomiasis Discussed - intestinal schistosomiasis vaccine, L-Praziquantel, schistosomiasis vaccine, Small Molecule for Schistosomiasis
Schistosomiasis (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.The pipeline guide provides a snapshot of the global therapeutic landscape of Schistosomiasis (Infectious Disease). The pipeline guide reviews pipeline therapeutics for Schistosomiasis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Schistosomiasis (Infectious Disease) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Schistosomiasis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. The pipeline guide reviews latest news related to pipeline therapeutics for Schistosomiasis (Infectious Disease)
List of Tables:
- Number of Products under Development for Schistosomiasis, H1 2017
- Number of Products under Development by Companies, H1 2017
- Number of Products under Development by Universities/Institutes, H1 2017
- Products under Development by Companies, H1 2017
- Products under Development by Universities/Institutes, H1 2017
- Number of Products by Stage and Route of Administration, H1 2017
- Number of Products by Stage and Molecule Type, H1 2017
- Schistosomiasis - Pipeline by Kancera AB, H1 2017
- Schistosomiasis - Pipeline by LondonPharma Ltd, H1 2017
- Schistosomiasis - Pipeline by Merck KGaA, H1 2017
- Schistosomiasis - Pipeline by Salvensis, H1 2017
- Schistosomiasis - Dormant Projects, H1 2017
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441
E-mail: sales@ reportsnreports.com
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.